研究单位：[1]InventisBio Co.,Ltd[2]First Affiliated Hospital of Kunming Medical University Kunming,China[3]Inner Mongolia Baogang Hospital Baotou,China[4]Peking Union Medical College Hospital Beijing,China[5]The First Hospital of Jilin University Changchun,China[6]The First People's Hospital of Changzhou Changzhou,China[7]Foshan Nanhai People's Hospital Foshan,China[8]Guangzhou First People's Hospital Guangzhou,China[9]Nanfang Hospital Guangzhou,China[10]The Second People's Hospital of Guangdong Province Guangzhou,China
研究目的：
This is a randomized, open-label, parallel-controlled, multicenter clinical trial in primary hyperuricemia patients with or without gout.
